選択的エストロゲン受容体分解剤のグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Selective Estrogen Receptor Degrader Market Insights and Forecast to 2027

• レポートコード：QY2112C03926
• 出版社/出版日：QYResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査資料は選択的エストロゲン受容体分解剤の世界市場の現状について調査・分析し、2027年までの市場を予測しました。選択的エストロゲン受容体分解剤の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・選択的エストロゲン受容体分解剤の世界市場概要
・メーカー別の競争状況、市場シェア
・選択的エストロゲン受容体分解剤の種類別市場規模：経口、注射
・選択的エストロゲン受容体分解剤の用途別市場規模：病院、研究所、その他
・北米の選択的エストロゲン受容体分解剤市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ）
・ヨーロッパの選択的エストロゲン受容体分解剤市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス）
・アジアの選択的エストロゲン受容体分解剤市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国）
・中南米の選択的エストロゲン受容体分解剤市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル）
・中東・アフリカの選択的エストロゲン受容体分解剤市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア）
・企業情報：AstraZeneca、Eli Lilly and Company、G1 Therapeutics、Olema Oncology、Novartis、Sanofi、Roche、Zentalis Pharmaceuticals、Radius
・選択的エストロゲン受容体分解剤のバリューチェーン・販売チャネル分析
・選択的エストロゲン受容体分解剤の世界市場動向

Market Analysis and Insights: Global Selective Estrogen Receptor Degrader Market
The global Selective Estrogen Receptor Degrader market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.

Global Selective Estrogen Receptor Degrader Scope and Segment
Selective Estrogen Receptor Degrader market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Selective Estrogen Receptor Degrader market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Oral
Injection

Segment by Application
Hospital
Research Institute
Others

By Company
AstraZeneca
Eli Lilly and Company
G1 Therapeutics
Olema Oncology
Novartis
Sanofi
Roche
Zentalis Pharmaceuticals
Radius

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Selective Estrogen Receptor Degrader Product Introduction
1.2 Market by Type
1.2.1 Global Selective Estrogen Receptor Degrader Market Size Growth Rate by Type
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Selective Estrogen Receptor Degrader Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Selective Estrogen Receptor Degrader Sales Estimates and Forecasts 2016-2027
2.2 Global Selective Estrogen Receptor Degrader Revenue Estimates and Forecasts 2016-2027
2.3 Global Selective Estrogen Receptor Degrader Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Selective Estrogen Receptor Degrader Regions by Sales
2.4.1 Global Top Selective Estrogen Receptor Degrader Regions by Sales (2016-2021)
2.4.2 Global Top Selective Estrogen Receptor Degrader Regions by Sales (2022-2027)
2.5 Global Top Selective Estrogen Receptor Degrader Regions by Revenue
2.5.1 Global Top Selective Estrogen Receptor Degrader Regions by Revenue (2016-2021)
2.5.2 Global Top Selective Estrogen Receptor Degrader Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Selective Estrogen Receptor Degrader Sales by Manufacturers
3.1.1 Global Top Selective Estrogen Receptor Degrader Manufacturers by Sales (2016-2021)
3.1.2 Global Top Selective Estrogen Receptor Degrader Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Selective Estrogen Receptor Degrader Sales in 2020
3.2 Global Selective Estrogen Receptor Degrader Revenue by Manufacturers
3.2.1 Global Top Selective Estrogen Receptor Degrader Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Selective Estrogen Receptor Degrader Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Selective Estrogen Receptor Degrader Revenue in 2020
3.3 Global Selective Estrogen Receptor Degrader Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Selective Estrogen Receptor Degrader Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Selective Estrogen Receptor Degrader Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Selective Estrogen Receptor Degrader Sales by Type
4.1.1 Global Selective Estrogen Receptor Degrader Historical Sales by Type (2016-2021)
4.1.2 Global Selective Estrogen Receptor Degrader Forecasted Sales by Type (2022-2027)
4.1.3 Global Selective Estrogen Receptor Degrader Sales Market Share by Type (2016-2027)
4.2 Global Selective Estrogen Receptor Degrader Revenue by Type
4.2.1 Global Selective Estrogen Receptor Degrader Historical Revenue by Type (2016-2021)
4.2.2 Global Selective Estrogen Receptor Degrader Forecasted Revenue by Type (2022-2027)
4.2.3 Global Selective Estrogen Receptor Degrader Revenue Market Share by Type (2016-2027)
4.3 Global Selective Estrogen Receptor Degrader Price by Type
4.3.1 Global Selective Estrogen Receptor Degrader Price by Type (2016-2021)
4.3.2 Global Selective Estrogen Receptor Degrader Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Selective Estrogen Receptor Degrader Sales by Application
5.1.1 Global Selective Estrogen Receptor Degrader Historical Sales by Application (2016-2021)
5.1.2 Global Selective Estrogen Receptor Degrader Forecasted Sales by Application (2022-2027)
5.1.3 Global Selective Estrogen Receptor Degrader Sales Market Share by Application (2016-2027)
5.2 Global Selective Estrogen Receptor Degrader Revenue by Application
5.2.1 Global Selective Estrogen Receptor Degrader Historical Revenue by Application (2016-2021)
5.2.2 Global Selective Estrogen Receptor Degrader Forecasted Revenue by Application (2022-2027)
5.2.3 Global Selective Estrogen Receptor Degrader Revenue Market Share by Application (2016-2027)
5.3 Global Selective Estrogen Receptor Degrader Price by Application
5.3.1 Global Selective Estrogen Receptor Degrader Price by Application (2016-2021)
5.3.2 Global Selective Estrogen Receptor Degrader Price Forecast by Application (2022-2027)

6 North America
6.1 North America Selective Estrogen Receptor Degrader Market Size by Type
6.1.1 North America Selective Estrogen Receptor Degrader Sales by Type (2016-2027)
6.1.2 North America Selective Estrogen Receptor Degrader Revenue by Type (2016-2027)
6.2 North America Selective Estrogen Receptor Degrader Market Size by Application
6.2.1 North America Selective Estrogen Receptor Degrader Sales by Application (2016-2027)
6.2.2 North America Selective Estrogen Receptor Degrader Revenue by Application (2016-2027)
6.3 North America Selective Estrogen Receptor Degrader Market Size by Country
6.3.1 North America Selective Estrogen Receptor Degrader Sales by Country (2016-2027)
6.3.2 North America Selective Estrogen Receptor Degrader Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Selective Estrogen Receptor Degrader Market Size by Type
7.1.1 Europe Selective Estrogen Receptor Degrader Sales by Type (2016-2027)
7.1.2 Europe Selective Estrogen Receptor Degrader Revenue by Type (2016-2027)
7.2 Europe Selective Estrogen Receptor Degrader Market Size by Application
7.2.1 Europe Selective Estrogen Receptor Degrader Sales by Application (2016-2027)
7.2.2 Europe Selective Estrogen Receptor Degrader Revenue by Application (2016-2027)
7.3 Europe Selective Estrogen Receptor Degrader Market Size by Country
7.3.1 Europe Selective Estrogen Receptor Degrader Sales by Country (2016-2027)
7.3.2 Europe Selective Estrogen Receptor Degrader Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Selective Estrogen Receptor Degrader Market Size by Type
8.1.1 Asia Pacific Selective Estrogen Receptor Degrader Sales by Type (2016-2027)
8.1.2 Asia Pacific Selective Estrogen Receptor Degrader Revenue by Type (2016-2027)
8.2 Asia Pacific Selective Estrogen Receptor Degrader Market Size by Application
8.2.1 Asia Pacific Selective Estrogen Receptor Degrader Sales by Application (2016-2027)
8.2.2 Asia Pacific Selective Estrogen Receptor Degrader Revenue by Application (2016-2027)
8.3 Asia Pacific Selective Estrogen Receptor Degrader Market Size by Region
8.3.1 Asia Pacific Selective Estrogen Receptor Degrader Sales by Region (2016-2027)
8.3.2 Asia Pacific Selective Estrogen Receptor Degrader Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Selective Estrogen Receptor Degrader Market Size by Type
9.1.1 Latin America Selective Estrogen Receptor Degrader Sales by Type (2016-2027)
9.1.2 Latin America Selective Estrogen Receptor Degrader Revenue by Type (2016-2027)
9.2 Latin America Selective Estrogen Receptor Degrader Market Size by Application
9.2.1 Latin America Selective Estrogen Receptor Degrader Sales by Application (2016-2027)
9.2.2 Latin America Selective Estrogen Receptor Degrader Revenue by Application (2016-2027)
9.3 Latin America Selective Estrogen Receptor Degrader Market Size by Country
9.3.1 Latin America Selective Estrogen Receptor Degrader Sales by Country (2016-2027)
9.3.2 Latin America Selective Estrogen Receptor Degrader Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Selective Estrogen Receptor Degrader Market Size by Type
10.1.1 Middle East and Africa Selective Estrogen Receptor Degrader Sales by Type (2016-2027)
10.1.2 Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Type (2016-2027)
10.2 Middle East and Africa Selective Estrogen Receptor Degrader Market Size by Application
10.2.1 Middle East and Africa Selective Estrogen Receptor Degrader Sales by Application (2016-2027)
10.2.2 Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Application (2016-2027)
10.3 Middle East and Africa Selective Estrogen Receptor Degrader Market Size by Country
10.3.1 Middle East and Africa Selective Estrogen Receptor Degrader Sales by Country (2016-2027)
10.3.2 Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AstraZeneca Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Corporation Information
11.2.2 Eli Lilly and Company Overview
11.2.3 Eli Lilly and Company Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Eli Lilly and Company Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly and Company Recent Developments
11.3 G1 Therapeutics
11.3.1 G1 Therapeutics Corporation Information
11.3.2 G1 Therapeutics Overview
11.3.3 G1 Therapeutics Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 G1 Therapeutics Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 G1 Therapeutics Recent Developments
11.4 Olema Oncology
11.4.1 Olema Oncology Corporation Information
11.4.2 Olema Oncology Overview
11.4.3 Olema Oncology Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Olema Oncology Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Olema Oncology Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Novartis Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Sanofi Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Overview
11.7.3 Roche Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Roche Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Roche Recent Developments
11.8 Zentalis Pharmaceuticals
11.8.1 Zentalis Pharmaceuticals Corporation Information
11.8.2 Zentalis Pharmaceuticals Overview
11.8.3 Zentalis Pharmaceuticals Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Zentalis Pharmaceuticals Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zentalis Pharmaceuticals Recent Developments
11.9 Radius
11.9.1 Radius Corporation Information
11.9.2 Radius Overview
11.9.3 Radius Selective Estrogen Receptor Degrader Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Radius Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Radius Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Selective Estrogen Receptor Degrader Value Chain Analysis
12.2 Selective Estrogen Receptor Degrader Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Selective Estrogen Receptor Degrader Production Mode & Process
12.4 Selective Estrogen Receptor Degrader Sales and Marketing
12.4.1 Selective Estrogen Receptor Degrader Sales Channels
12.4.2 Selective Estrogen Receptor Degrader Distributors
12.5 Selective Estrogen Receptor Degrader Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Selective Estrogen Receptor Degrader Industry Trends
13.2 Selective Estrogen Receptor Degrader Market Drivers
13.3 Selective Estrogen Receptor Degrader Market Challenges
13.4 Selective Estrogen Receptor Degrader Market Restraints

14 Key Findings in The Global Selective Estrogen Receptor Degrader Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Selective Estrogen Receptor Degrader Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Injection
Table 4. Global Selective Estrogen Receptor Degrader Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Selective Estrogen Receptor Degrader Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Selective Estrogen Receptor Degrader Sales by Region (2016-2021) & (K Units)
Table 7. Global Selective Estrogen Receptor Degrader Sales Market Share by Region (2016-2021)
Table 8. Global Selective Estrogen Receptor Degrader Sales by Region (2022-2027) & (K Units)
Table 9. Global Selective Estrogen Receptor Degrader Sales Market Share by Region (2022-2027)
Table 10. Global Selective Estrogen Receptor Degrader Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Selective Estrogen Receptor Degrader Revenue Market Share by Region (2016-2021)
Table 12. Global Selective Estrogen Receptor Degrader Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Selective Estrogen Receptor Degrader Revenue Market Share by Region (2022-2027)
Table 14. Global Selective Estrogen Receptor Degrader Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Selective Estrogen Receptor Degrader Sales Share by Manufacturers (2016-2021)
Table 16. Global Selective Estrogen Receptor Degrader Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Selective Estrogen Receptor Degrader Revenue Share by Manufacturers (2016-2021)
Table 18. Selective Estrogen Receptor Degrader Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Selective Estrogen Receptor Degrader Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Selective Estrogen Receptor Degrader by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Selective Estrogen Receptor Degrader as of 2020)
Table 21. Selective Estrogen Receptor Degrader Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Selective Estrogen Receptor Degrader Product Offered
Table 23. Date of Manufacturers Enter into Selective Estrogen Receptor Degrader Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Selective Estrogen Receptor Degrader Sales by Type (2016-2021) & (K Units)
Table 26. Global Selective Estrogen Receptor Degrader Sales by Type (2022-2027) & (K Units)
Table 27. Global Selective Estrogen Receptor Degrader Sales Share by Type (2016-2021)
Table 28. Global Selective Estrogen Receptor Degrader Sales Share by Type (2022-2027)
Table 29. Global Selective Estrogen Receptor Degrader Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Selective Estrogen Receptor Degrader Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Selective Estrogen Receptor Degrader Revenue Share by Type (2016-2021)
Table 32. Global Selective Estrogen Receptor Degrader Revenue Share by Type (2022-2027)
Table 33. Selective Estrogen Receptor Degrader Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Selective Estrogen Receptor Degrader Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Selective Estrogen Receptor Degrader Sales by Application (2016-2021) & (K Units)
Table 36. Global Selective Estrogen Receptor Degrader Sales by Application (2022-2027) & (K Units)
Table 37. Global Selective Estrogen Receptor Degrader Sales Share by Application (2016-2021)
Table 38. Global Selective Estrogen Receptor Degrader Sales Share by Application (2022-2027)
Table 39. Global Selective Estrogen Receptor Degrader Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Selective Estrogen Receptor Degrader Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Selective Estrogen Receptor Degrader Revenue Share by Application (2016-2021)
Table 42. Global Selective Estrogen Receptor Degrader Revenue Share by Application (2022-2027)
Table 43. Selective Estrogen Receptor Degrader Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Selective Estrogen Receptor Degrader Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Selective Estrogen Receptor Degrader Sales by Type (2016-2021) & (K Units)
Table 46. North America Selective Estrogen Receptor Degrader Sales by Type (2022-2027) & (K Units)
Table 47. North America Selective Estrogen Receptor Degrader Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Selective Estrogen Receptor Degrader Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Selective Estrogen Receptor Degrader Sales by Application (2016-2021) & (K Units)
Table 50. North America Selective Estrogen Receptor Degrader Sales by Application (2022-2027) & (K Units)
Table 51. North America Selective Estrogen Receptor Degrader Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Selective Estrogen Receptor Degrader Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Selective Estrogen Receptor Degrader Sales by Country (2016-2021) & (K Units)
Table 54. North America Selective Estrogen Receptor Degrader Sales by Country (2022-2027) & (K Units)
Table 55. North America Selective Estrogen Receptor Degrader Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Selective Estrogen Receptor Degrader Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Selective Estrogen Receptor Degrader Sales by Type (2016-2021) & (K Units)
Table 58. Europe Selective Estrogen Receptor Degrader Sales by Type (2022-2027) & (K Units)
Table 59. Europe Selective Estrogen Receptor Degrader Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Selective Estrogen Receptor Degrader Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Selective Estrogen Receptor Degrader Sales by Application (2016-2021) & (K Units)
Table 62. Europe Selective Estrogen Receptor Degrader Sales by Application (2022-2027) & (K Units)
Table 63. Europe Selective Estrogen Receptor Degrader Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Selective Estrogen Receptor Degrader Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Selective Estrogen Receptor Degrader Sales by Country (2016-2021) & (K Units)
Table 66. Europe Selective Estrogen Receptor Degrader Sales by Country (2022-2027) & (K Units)
Table 67. Europe Selective Estrogen Receptor Degrader Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Selective Estrogen Receptor Degrader Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Selective Estrogen Receptor Degrader Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Selective Estrogen Receptor Degrader Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Selective Estrogen Receptor Degrader Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Selective Estrogen Receptor Degrader Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Selective Estrogen Receptor Degrader Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Selective Estrogen Receptor Degrader Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Selective Estrogen Receptor Degrader Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Selective Estrogen Receptor Degrader Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Selective Estrogen Receptor Degrader Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Selective Estrogen Receptor Degrader Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Selective Estrogen Receptor Degrader Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Selective Estrogen Receptor Degrader Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Selective Estrogen Receptor Degrader Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Selective Estrogen Receptor Degrader Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Selective Estrogen Receptor Degrader Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Selective Estrogen Receptor Degrader Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Selective Estrogen Receptor Degrader Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Selective Estrogen Receptor Degrader Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Selective Estrogen Receptor Degrader Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Selective Estrogen Receptor Degrader Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Selective Estrogen Receptor Degrader Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Selective Estrogen Receptor Degrader Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Selective Estrogen Receptor Degrader Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Selective Estrogen Receptor Degrader Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Selective Estrogen Receptor Degrader Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Selective Estrogen Receptor Degrader Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Selective Estrogen Receptor Degrader Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Selective Estrogen Receptor Degrader Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Selective Estrogen Receptor Degrader Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Selective Estrogen Receptor Degrader Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Selective Estrogen Receptor Degrader Revenue by Country (2022-2027) & (US$ Million)
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Major Businesses
Table 107. AstraZeneca Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. AstraZeneca Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. AstraZeneca Recent Developments
Table 110. Eli Lilly and Company Corporation Information
Table 111. Eli Lilly and Company Description and Major Businesses
Table 112. Eli Lilly and Company Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Eli Lilly and Company Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Eli Lilly and Company Recent Developments
Table 115. G1 Therapeutics Corporation Information
Table 116. G1 Therapeutics Description and Major Businesses
Table 117. G1 Therapeutics Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. G1 Therapeutics Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. G1 Therapeutics Recent Developments
Table 120. Olema Oncology Corporation Information
Table 121. Olema Oncology Description and Major Businesses
Table 122. Olema Oncology Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Olema Oncology Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Olema Oncology Recent Developments
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Major Businesses
Table 127. Novartis Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Novartis Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novartis Recent Developments
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Major Businesses
Table 132. Sanofi Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Sanofi Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sanofi Recent Developments
Table 135. Roche Corporation Information
Table 136. Roche Description and Major Businesses
Table 137. Roche Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Roche Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Roche Recent Developments
Table 140. Zentalis Pharmaceuticals Corporation Information
Table 141. Zentalis Pharmaceuticals Description and Major Businesses
Table 142. Zentalis Pharmaceuticals Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Zentalis Pharmaceuticals Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Zentalis Pharmaceuticals Recent Developments
Table 145. Radius Corporation Information
Table 146. Radius Description and Major Businesses
Table 147. Radius Selective Estrogen Receptor Degrader Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. Radius Selective Estrogen Receptor Degrader Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Radius Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Selective Estrogen Receptor Degrader Distributors List
Table 153. Selective Estrogen Receptor Degrader Customers List
Table 154. Selective Estrogen Receptor Degrader Market Trends
Table 155. Selective Estrogen Receptor Degrader Market Drivers
Table 156. Selective Estrogen Receptor Degrader Market Challenges
Table 157. Selective Estrogen Receptor Degrader Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Selective Estrogen Receptor Degrader Product Picture
Figure 2. Global Selective Estrogen Receptor Degrader Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Selective Estrogen Receptor Degrader Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Research Institute
Figure 8. Others
Figure 9. Selective Estrogen Receptor Degrader Report Years Considered
Figure 10. Global Selective Estrogen Receptor Degrader Sales 2016-2027 (K Units)
Figure 11. Global Selective Estrogen Receptor Degrader Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Selective Estrogen Receptor Degrader Revenue 2016-2027 (US$ Million)
Figure 13. Global Selective Estrogen Receptor Degrader Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Selective Estrogen Receptor Degrader Sales Market Share by Region (2016-2021)
Figure 15. Global Selective Estrogen Receptor Degrader Sales Market Share by Region (2022-2027)
Figure 16. North America Selective Estrogen Receptor Degrader Sales YoY (2016-2027) & (K Units)
Figure 17. North America Selective Estrogen Receptor Degrader Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Selective Estrogen Receptor Degrader Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Selective Estrogen Receptor Degrader Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Selective Estrogen Receptor Degrader Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Selective Estrogen Receptor Degrader Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Selective Estrogen Receptor Degrader Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Selective Estrogen Receptor Degrader Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Selective Estrogen Receptor Degrader Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Selective Estrogen Receptor Degrader Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Selective Estrogen Receptor Degrader Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Selective Estrogen Receptor Degrader Revenue in 2020
Figure 28. Selective Estrogen Receptor Degrader Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Selective Estrogen Receptor Degrader Sales Market Share by Type (2016-2027)
Figure 30. Global Selective Estrogen Receptor Degrader Revenue Market Share by Type (2016-2027)
Figure 31. Global Selective Estrogen Receptor Degrader Sales Market Share by Application (2016-2027)
Figure 32. Global Selective Estrogen Receptor Degrader Revenue Market Share by Application (2016-2027)
Figure 33. North America Selective Estrogen Receptor Degrader Sales Market Share by Type (2016-2027)
Figure 34. North America Selective Estrogen Receptor Degrader Revenue Market Share by Type (2016-2027)
Figure 35. North America Selective Estrogen Receptor Degrader Sales Market Share by Application (2016-2027)
Figure 36. North America Selective Estrogen Receptor Degrader Revenue Market Share by Application (2016-2027)
Figure 37. North America Selective Estrogen Receptor Degrader Sales Share by Country (2016-2027)
Figure 38. North America Selective Estrogen Receptor Degrader Revenue Share by Country (2016-2027)
Figure 39. United States Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Selective Estrogen Receptor Degrader Sales Market Share by Type (2016-2027)
Figure 42. Europe Selective Estrogen Receptor Degrader Revenue Market Share by Type (2016-2027)
Figure 43. Europe Selective Estrogen Receptor Degrader Sales Market Share by Application (2016-2027)
Figure 44. Europe Selective Estrogen Receptor Degrader Revenue Market Share by Application (2016-2027)
Figure 45. Europe Selective Estrogen Receptor Degrader Sales Share by Country (2016-2027)
Figure 46. Europe Selective Estrogen Receptor Degrader Revenue Share by Country (2016-2027)
Figure 47. Germany Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 48. France Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Selective Estrogen Receptor Degrader Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Selective Estrogen Receptor Degrader Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Selective Estrogen Receptor Degrader Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Selective Estrogen Receptor Degrader Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Selective Estrogen Receptor Degrader Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Selective Estrogen Receptor Degrader Revenue Share by Region (2016-2027)
Figure 58. China Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 61. India Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Selective Estrogen Receptor Degrader Sales Market Share by Type (2016-2027)
Figure 68. Latin America Selective Estrogen Receptor Degrader Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Selective Estrogen Receptor Degrader Sales Market Share by Application (2016-2027)
Figure 70. Latin America Selective Estrogen Receptor Degrader Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Selective Estrogen Receptor Degrader Sales Share by Country (2016-2027)
Figure 72. Latin America Selective Estrogen Receptor Degrader Revenue Share by Country (2016-2027)
Figure 73. Mexico Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Selective Estrogen Receptor Degrader Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Selective Estrogen Receptor Degrader Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Selective Estrogen Receptor Degrader Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Selective Estrogen Receptor Degrader Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Selective Estrogen Receptor Degrader Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Selective Estrogen Receptor Degrader Revenue Share by Country (2016-2027)
Figure 82. Turkey Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Selective Estrogen Receptor Degrader Revenue (2016-2027) & (US$ Million)
Figure 85. Selective Estrogen Receptor Degrader Value Chain
Figure 86. Selective Estrogen Receptor Degrader Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

以下、関連資料のご紹介

低価格選択的レーザー焼結機のグローバル市場インサイト・予測（～2027年）

Global Low Cost Selective Laser Sintering Machine Market Insights and Forecast to 2027
QY2112C02524 2021年12月 107Pages
本調査資料は低価格選択的レーザー焼結機の世界市場の現状について調査・分析し、2027年までの市場を予測しました。低価格選択的レーザー焼結機の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（15000ドル以下、15000ドル～30000ドル）、用途別市場規模（オンライン、オフライン）、...

軟部組織再建ユニットのグローバル市場インサイト・予測（～2027年）

Global Soft Tissue Reconstruction Units Market Insights and Forecast to 2027
QY2112C03790 2021年12月 110Pages
本調査資料は軟部組織再建ユニットの世界市場の現状について調査・分析し、2027年までの市場を予測しました。軟部組織再建ユニットの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（生物ユニット、合成ユニット）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ...

サイズ排除クロマトグラフィー（SEC）HPLCカラムのグローバル市場インサイト・予測（～2027年）

Global Size Exclusion Chromatography (SEC) HPLC Column Market Insights and Forecast to 2027
QY2112C03776 2021年12月 105Pages
本調査資料はサイズ排除クロマトグラフィー（SEC）HPLCカラムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。サイズ排除クロマトグラフィー（SEC）HPLCカラムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ID <3.5 mm、ID 3.5-6 mm...

腹膜透析システムのグローバル市場インサイト・予測（～2027年）

Global Peritoneal Dialysis Systems Market Insights and Forecast to 2027
QY2112C03646 2021年12月 95Pages
本調査資料は腹膜透析システムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。腹膜透析システムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（自動腹膜透析（APD）、継続的携帯型腹膜透析（CAPD）、その他）、用途別市場規模（病院、クリニック、その他）、主要...

上腕骨スペーサーのグローバル市場インサイト・予測（～2027年）

Global Humeral Spacer Market Insights and Forecast to 2027
QY2112C03413 2021年12月 104Pages
本調査資料は上腕骨スペーサーの世界市場の現状について調査・分析し、2027年までの市場を予測しました。上腕骨スペーサーの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（8〜14mm、16〜20mm）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨー...

マイクロカテーテル・マイクロガイドワイヤーのグローバル市場インサイト・予測（～2027年）

Global Micro Catheter and Micro Guidewire Market Insights and Forecast to 2027
QY2112C03539 2021年12月 125Pages
本調査資料はマイクロカテーテル・マイクロガイドワイヤーの世界市場の現状について調査・分析し、2027年までの市場を予測しました。マイクロカテーテル・マイクロガイドワイヤーの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（マイクロカテーテル、マイクロガイドワイヤー）、用途別市場規模（病...

マグネットホルダーのグローバル市場インサイト・予測（～2027年）

Global Magnet Holder Market Insights and Forecast to 2027
QY2112C03477 2021年12月 95Pages
本調査資料はマグネットホルダーの世界市場の現状について調査・分析し、2027年までの市場を予測しました。マグネットホルダーの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（白色、青色、スミレ色、灰色、その他）、用途別市場規模（研究室、病院、その他）、主要地域別市場規模（北米・アメリカ...

プラスチック舌圧子のグローバル市場インサイト・予測（～2027年）

Global Plastic Tongue Depressors Market Insights and Forecast to 2027
QY2112C03668 2021年12月 110Pages
本調査資料はプラスチック舌圧子の世界市場の現状について調査・分析し、2027年までの市場を予測しました。プラスチック舌圧子の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ストレート、カーブ）、用途別市場規模（病院、クリニック、学術研究機関、その他）、主要地域別市場規模（北米・アメリ...

リチウムイオン充電式補聴器のグローバル市場インサイト・予測（～2027年）

Global Lithium-Ion Rechargeable Hearing Aid Market Insights and Forecast to 2027
QY2112C03466 2021年12月 99Pages
本調査資料はリチウムイオン充電式補聴器の世界市場の現状について調査・分析し、2027年までの市場を予測しました。リチウムイオン充電式補聴器の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（RIC、BTE、ITE、ITC）、用途別市場規模（成人、子供）、主要地域別市場規模（北米・アメリ...

純皮質骨顆粒のグローバル市場インサイト・予測（～2027年）

Global Pure Cortical Bone Granules Market Insights and Forecast to 2027
QY2112C03710 2021年12月 109Pages
本調査資料は純皮質骨顆粒の世界市場の現状について調査・分析し、2027年までの市場を予測しました。純皮質骨顆粒の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（500μm–1000μm、1000μm–1500μm、その他）、用途別市場規模（病院、整形外科クリニック、その他）、主要地域...

低価格選択的レーザー焼結機のグローバル市場インサイト・予測（～2027年） SLS (Selective Laser Sintering) is a 3D printing technology that uses a laser beam to sinter powdered material. This technique enables the 3D printing of detailed functional parts and prototypes. Five to ten years ago, SLS technology was exclusive to large, industrial additive manufacturing systems.…
経口ジドロゲステロンのグローバル市場インサイト・予測（～2027年） Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndro…
経口セラミックブラケットのグローバル市場インサイト・予測（～2027年） Ceramic brackets are used to create braces that blend in with a patient's teeth, making their orthodontic treatment less invasive. Fabricated from high strength ceramic polymers, these brackets can be white or translucent, and often they are used with clear or white wires to be less visibly obvious.…
強制経口投与針のグローバル市場インサイト・予測（～2027年） Market Analysis and Insights: Global Oral Gavage Needle Market The global Oral Gavage Needle market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027. Global Oral Gavage Needle Scope and Segment Oral Gavage Needle mar…
注入済みワイプのグローバル市場インサイト・予測（～2027年） Pre-Injection Wipe acts as a disinfectant to clean and remove bacteria prior to administering an injection. Market Analysis and Insights: Global Pre-Injection Wipes Market The global Pre-Injection Wipes market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end …